Treatment of Parkinson’s disease with agents other than Levodopa and Dopamine Agonists: controversies and new approaches
Open Access
- 1 February 1984
- journal article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 11 (S1), 210-220
- https://doi.org/10.1017/s0317167100046436
Abstract
Parkinson’s disease is associated with a variety of neurotransmitter disturbances which may be further altered by its treatment with dopamine agonists. Based on this information a wide range of pharmacological approaches have been used in search of newer treatment alternatives and in hopes of reducing complications of long-term levodopa use. This paper reviews the various therapies which have had some success in the management of Parkinson’s disease, other than levodopa and dopamine agonists. Special emphasis is placed on the many unresolved questions and controversies that exist in this area of neuropharmacology.Keywords
This publication has 102 references indexed in Scilit:
- SUCCESSFUL TREATMENT OF DEPRESSION WITH TETRAHYDROBIOPTERINThe Lancet, 1983
- ZimelidineDrugs, 1982
- Electroconvulsive therapy in Parkinson's syndrome with ?on-off? phenomenonJournal of Neural Transmission, 1980
- Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administrationJournal of Neural Transmission, 1978
- L-deprenyl treatment of on-off phenomena in Parkinson's diseaseJournal of Neural Transmission, 1978
- Overview of present day treatment of Parkinson's diseaseJournal of Neural Transmission, 1978
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal of Neural Transmission, 1978
- Amantadine Intoxication Reversed by PhysostigmineNew England Journal of Medicine, 1978
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975
- EFFECT OF ADRENERGIC β-BLOCKADE ON PARKINSONIAN TREMORThe Lancet, 1965